[HTML][HTML] Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute …

G Filippini Velázquez, M Labopin, J Tischer… - Bone Marrow …, 2023 - nature.com
For patients with acute myeloid and lymphoblastic leukaemia (AML/ALL) lacking a matched
sibling or unrelated donor, haploidentical stem cell transplantation (HAPLO-SCT) is …

[HTML][HTML] A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

S Piemontese, F Ciceri, M Labopin, W Arcese… - Journal of hematology & …, 2017 - Springer
Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …

Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia—an update on behalf of the ALWP of the EBMT

A Nagler, A Ruggeri - Bone marrow transplantation, 2019 - nature.com
Allogeneic stem cell transplantations (alloSCT) from haploidentical (> 2 HLA mismatch)
donors (HaploSCT) are constantly increasing in Europe. From 2005 to 2015 numbers of …

[HTML][HTML] Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a …

A Nagler, M Labopin, M Houhou, M Aljurf… - Journal of Hematology & …, 2021 - Springer
Background Non-T-cell depleted haploidentical hematopoietic stem cell transplantation
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …

[HTML][HTML] Haploidentical stem cell transplantation for acute myeloid leukemia: current therapies, challenges and future prospective

YJ Chang, XY Zhao, XJ Huang - Frontiers in Oncology, 2021 - frontiersin.org
Haploidentical stem cell transplantation (haplo-SCT), an alternative donor source, offers a
curative therapy for patients with acute myeloid leukemia (AML) who are transplant …

[HTML][HTML] Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute …

E Brissot, M Labopin, G Ehninger, M Stelljes… - …, 2019 - ncbi.nlm.nih.gov
Primary refractory or relapsed acute myeloid leukemia is associated with a dismal
prognosis. Allogeneic stem cell transplantation is the only therapeutic option that offers …

T‐cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the …

S Sestili, M Labopin, A Ruggeri, A Velardi, F Ciceri… - Cancer, 2018 - Wiley Online Library
BACKGROUND T‐cell–depleted, haploidentical transplantations (haplos) are commonly
offered to patients who have high‐risk, acute leukemia in the absence of a human leukocyte …

[HTML][HTML] Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia …

D Salvatore, M Labopin, A Ruggeri, G Battipaglia… - …, 2018 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …

[HTML][HTML] T-cell-replete haploidentical transplantation in acute myeloid leukemia

L Castagna, R Devillier, N Vey, D Blaise - Experimental Hematology, 2018 - Elsevier
Highlights•Outcome after haploidentical hematopoietic stem cell transplantation (haplo-
HSCT) for acute myeloid leukemia (AML) is similar to that using HLA-identical (HLAid) …

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

S Piemontese, F Ciceri, M Labopin, A Bacigalupo… - Leukemia, 2015 - nature.com
The use of unmanipulated graft is increasingly adopted in the setting of allogeneic
hematopoietic stem cell transplantation from haploidentical family donors (haplo-SCT) in …